Lumos Pharma, Inc. (LUMO)

Trade LUMO now with
2/28/2020 9:15:54 AM NewLink Genetics Q4 Net Loss $8.3 Mln Or $0.22 Per Share
4/2/2019 8:18:23 AM NewLink Genetics Presents Encouraging Phase 2 Results For NLG207 In Ovarian Cancer At AACR 2019
11/15/2018 9:13:52 AM NewLink Genetics Says Merck Begins Rolling Submission Of Licensure Application For Ebola Vaccine V920 To FDA
7/2/2018 8:08:11 AM NewLink Genetics Presents Positive Updated Phase 1 Data With Indoximod Plus Radio-Immunotherapy
4/15/2018 5:01:05 PM NewLink Genetics Announces Initial Phase 1 Data With Indoximod Plus Radiation And Chemotherapy
4/6/2018 3:03:01 PM NewLink Genetics Announces Review Of Clinical Programs
1/8/2018 8:25:35 AM NewLink Genetics Updates Clinical And Financial Guidance
11/2/2017 8:19:16 AM NewLink Genetics Q3 Net Loss $20.6 Mln Or $0.69/Shr Vs Loss Of $15.5 Mln Or $0.54/Shr Last Year
10/30/2017 9:06:03 AM NewLink Genetics Says Indoximod Granted Orphan-drug Designation By FDA
10/3/2017 9:09:05 PM NewLink Genetics Announces Pricing Of Underwritten Public Offering Of 5 Mln Shares At $10.25/shr